Tender Details

Country: Germany
Summary: Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Atovaquone
DET Ref No: 98664177
Deadline: 10 May 2024
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: EUR 1
Notice Type: Tender
Document Ref. No.: 150631-2024
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Section 130a Paragraph 8 SGB V enables health insurance companies (KK) and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory KK. The GWQ is a society for efficiency and quality at KK in accordance with Section 130a Paragraph 8 Sentence 5 SGBV for its Ashareholder and customer funds. With regard to the relevant legal regulations for the awarding of public contracts, a regular process of active ingredient-related, formal procurement procedures takes place in accordance with the regulations of Part 4 of the GWB by GWQ ServicePlus AG. UntilWhen new drug discount agreements come into force, the GWQ would like to conclude drug discount agreements with all interested pharmaceutical companies. The contract starts on February 1st, 2023
Conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for medicinal products with the active ingredient Atovaquon
GWQ ServicePlus AG intends to enter into non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V to the above. to close the active ingredient. All interested companies can join this contract at any time during the contract term under the same conditions (approval model). The GWQassumes that this procedure does not fall within the scope of antitrust procurement law due to the lack of a selection decision and therefore the non-discriminatory access of all pharmaceutical companies. The contract documents, the participating health insurance companies and d...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Atovaquone - Germany Tender

The GWQ SERVICEPLUS AG, a Government sector organization in Germany, has announced a new tender for Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Atovaquone. This tender is published on GermanyTenders under DET Ref No: 98664177 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-05-10.

The estimated tender value is EUR 1, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.